05/15/2025
8:22 AM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G | |
05/15/2025
8:23 AM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
8:24 AM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
11:29 AM | JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G/A | |
04/28/2025
5:27 PM | Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
03/24/2025
3:55 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:32 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025
4:40 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:40 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:41 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:42 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RVMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter. |
03/19/2025
4:43 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:43 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:42 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
4:14 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:47 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:18 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:02 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:03 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:00 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:01 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:01 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wei Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:02 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:02 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:44 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
3:10 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
10:25 AM | JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G | |
01/22/2025
4:30 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
3:50 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:09 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:06 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:07 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
8:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
7:42 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
7:01 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
6:39 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:57 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2024
3:18 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
New Rule Hits in July — The Smart Money Already Moved (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
12/03/2024
8:37 PM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form FWP | |
12/02/2024
4:21 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 424B5 | |
12/02/2024
6:30 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
9:52 AM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
4:07 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:05 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:43 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:30 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
5:43 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
5:05 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:29 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:31 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:03 AM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:16 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:23 PM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Weber Barbara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:16 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:06 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:41 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:22 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:37 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:15 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:24 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:23 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
3:15 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:48 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:07 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 424B5 | |
08/02/2024
4:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:29 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:27 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
7:03 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:36 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
07/10/2024
3:36 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:19 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:19 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
4:05 PM | Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024
4:08 PM | Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
